Physician profile
Lauren Zanetti
NPI 1578956538
$690.47
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.68 · 2022: $143 · 2023: $186 · 2024: $117 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.42 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $143.85 | 2023-2025 | Darzalex, Erleada |
| Daiichi Sankyo INC. | $106.94 | 2023-2025 | Injectafer, Vanflyta |
| Pharmacyclics LLC, An Abbvie Company | $101.59 | 2022-2023 | Imbruvica |
| Epizyme, INC. | $91.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $89.68 | 2021 | |
| Astellas Pharma US INC | $49.94 | 2025 | Vyloy |
| Rigel Pharmaceuticals, INC. | $33.53 | 2024 | Rezlidhia, Tavalisse |
| Abbvie INC. | $33.37 | 2025 | |
| Genmab U.S., INC. | $24.01 | 2024 | Tivdak |
| Seagen INC. | $16.20 | 2023 | Adcetris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Zanetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.